This feature requires access to the TospinoMall APP

FDA certification authority for liver cancer, kidney cancer, differentiated thyroid, Laos Daxiong Pharmaceutical Lenvatinib 4mg/10mg30 tablets

Indications:

10mg*30 tablets/box

1. Hepatocellular carcinoma: used to treat patients with unresectable hepatocellular carcinoma (HCC): 2. Differentiated thyroid cancer: single-agent for patients with local recurrence/metastasis and progression of radioactive iodine-refractory differentiated thyroid cancer; 3. Renal cell carcinoma: combined with everolimus, used to treat patients with advanced renal cell carcinoma who have previously received vascular endothelial growth factor targeted therapy.
Recommended dose: {For reference only, follow the doctor's advice}

1. Thyroid cancer (DTC): 24mg per day, orally, once a day; 2. Renal cell carcinoma (RCC): 18mg lenvatinib + 5mg everolimus
Oral, once a day;

3. Hepatocellular carcinoma (HCC): body weight > 60kg, 12mg, once a day: body weight < 60kg, 8mg, once a day.